Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 2/20 | 0.31 |
| ▸ | NCK1 | P16333 | 1/20 | 0.31 |
| ▸ | NCF1 | P14598 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29565102 | 0.85 | CDK1 (0.35) | MCHR1HTR2ANOS2NOS3NOS1 | |
| SCHEMBL31275671 | 0.71 | MCHR1 (0.33) | MCHR1NOS2NOS3NOS1BACE1 | |
| SCHEMBL15091312 | 0.71 | PIK3CB (0.44) | MCHR1NOS2NOS3NOS1BACE1 | |
| SCHEMBL26632865 | 0.68 | PIK3CB (0.46) | NOS2NOS3NOS1 | |
| SCHEMBL20350724 | 0.67 | CDK1 (0.37) | — | |
| SCHEMBL24334808 | 0.67 | CCNA2 (0.31) | — | |
| SCHEMBL26596995 | 0.67 | NOS2 (0.33) | MCHR1NOS2NOS3NOS1BACE1 | |
| SCHEMBL26658350 | 0.67 | CDK1 (0.35) | MCHR1NOS2NOS3NOS1BACE1 | |
| SCHEMBL26632791 | 0.66 | BACE1 (0.35) | NOS2NOS3NOS1BACE1NCK1 | |
| SCHEMBL16884032 | 0.64 | CCR1 (0.38) | HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | CAT, MPO, NISCH | MCHR1 3969/4885HTR2A 4785/4885NOS2 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.